This is an archive article published on May 12, 2025
Premium

Contracts, capex, and chemistry: Is Aether Industries building an Asian Paints of specialty chemicals?

Specialty chemicals company Aether Industries is expanding capacity and shifting focus toward high-value contract manufacturing. Its revenue grew from Rs 1,092 million in FY18 to Rs 6,511 million in FY23, and EBITDA margins hovered between 21% and 29%. But since its IPO in 2022, the stock has been flat, delivering essentially no returns. The question is: does Aether have the pieces in place to break out? Or is it another story where the promise is strong, but the execution needs to catch up?

Unlike peers who often scale on volumes or single chemistry platforms, Aether’s moat lies in its deep chemistry capabilities and R&D intensity.Unlike peers who often scale on volumes or single chemistry platforms, Aether’s moat lies in its deep chemistry capabilities and R&D intensity. (Aether Industries website)
Written by: Parth Parikh
12 min readMay 30, 2025 06:43 PM IST First published on: May 12, 2025 at 01:40 PM IST

There’s a new name doing the rounds in specialty chemicals: Aether Industries.

It’s young, R&D-driven, and already counts global giants like Baker Hughes and Saudi Aramco as its clients. The company is growing fast, expanding capacity, and shifting focus toward high-value contract manufacturing, a space investors tend to favour.

Advertisement

But here’s the catch: since its IPO in 2022, the stock has been flat. It had a brief 45% rally post-listing, but has since given up those gains. Over the last three years, it’s essentially delivered no returns, even as the broader market moved up and peers like SRF or PI kept compounding.

Latest Comment
Post Comment
Read Comments